Results 141 to 150 of about 108,435 (311)

Rituximab and Intravenous Immunoglobulin (IVIG) for Refractory Eosinophilic Fasciitis: A Case Report. [PDF]

Clin Case Rep
Sahebari M, Karimoddini M, Tayyebi Meibodi N, Ataei Azimi S, Tafreshian S.   +4 more
europepmc   +1 more source

Success of intravenous immunoglobulin and steroids in managing severe COVID-19 following lung transplantation: A case report

Yen‐Shou Kuo, Kuan‐Hsun Lin, Ying‐Yi Chen, Yuan-Ming Tsai, Ti-Hui Wu, Hsu‐Kai Huang, Tsai-Wang Huang   +6 more
openalex   +1 more source

T Cell Exhaustion in Cancer Immunotherapy: Heterogeneity, Mechanisms, and Therapeutic Opportunities

Advanced Science, EarlyView.
T cell exhaustion limits immunotherapy efficacy. This article delineates its progression from stem‐like to terminally exhausted states, governed by persistent antigen, transcription factors, epigenetics, and metabolism. It maps the exhaustion landscape in the TME and proposes integrated reversal strategies, providing a translational roadmap to overcome
Yang Yu, Xiaoyu Yao, Qingyang Wang, Mengrui Yang, Runze Li, Jiangjiang Qin, Jing Zhuang, Changgang Sun   +7 more
wiley   +1 more source

Comparison of intravenous efgartigimod and intravenous immunoglobulin in patients with Guillain-Barré syndrome. [PDF]

Orphanet J Rare Dis
Zhang H, Zhai F, Su M, Zhang Y, Ma J, Zhao J, Wang J, Chang X, Liu Y, Guo J, Zhang W.   +10 more
europepmc   +1 more source

High Dose Intravenous Immunoglobulin Does Not Affect Complement-Bacteria Interactions [PDF]

, 1998
Éric Wagner, Jeffrey L. Platt, Michael M. Frank   +2 more
openalex   +1 more source

Targeting the Mapk13‐Tcf1‐Slc7a5 Axis via One‐Carbon Metabolic Regulation to Prevent Chronic Allograft Vasculopathy

Advanced Science, EarlyView.
This study emphasizes the role of the Mapk13‐Tcf1‐Slc7a5‐methionine metabolism axis in stem‐like CD4+ T cells. Moreover, it uncovers the mechanism through which limiting one‐carbon metabolism in CD4+ stem‐like T cells suppresses the tide of chronic allograft vasculopathy, offering potential targets to promote long‐term graft survival.
Wang Yi, Di Wu, Jing Liu, Shi Chen, Liu Song, Bin Xie, Aini Xie, Peixiang Lan, Zhishui Chen   +8 more
wiley   +1 more source

Intravenous immunoglobulin for cutaneous chronic graft-versus-host disease. [PDF]

JAAD Case Rep
Chang TH, Greif T, Nayar J, Cardones AR.
europepmc   +1 more source

Plasmapheresis, intravenous immunoglobulin and fondaparinux treatment in heparin-induced thrombocytopenia after aortic and mitral valve replacement

, 2016
Mehmet Erdem Toker
openalex   +1 more source

Targeted Degradation of eEF2K by a Structure‐Guided PROTAC Strategy for the Treatment of Triple‐Negative Breast Cancer

Advanced Science, EarlyView.
This study developed an eEF2K‐targeting PROTAC, A6, that efficiently degrades eEF2K in TNBC cells, inhibiting tumor growth in vitro and in vivo. To enhance tumor‐specific delivery, we engineered A6@ZIF‐8, a pH‐sensitive nanocarrier, which improved drug accumulation at tumor sites, offering a promising therapeutic strategy for TNBC through targeted ...
Shijun Cao, Changxin Zhong, Shilong Jiang, Yungui Li, Yang Xi, Mingxuan Xiao, Ting Jiang, Xiaoya Wan, Zonglin Chen, Xiaohui Yu, Yan Cheng   +10 more
wiley   +1 more source

Chasing the Dragon Syndrome: A Case of Toxic Leukoencephalopathy and Response to Intravenous Immunoglobulin. [PDF]

Cureus
Puri P, Shadan J, Akhavan M, Farrukh M, Durrani R.   +4 more
europepmc   +1 more source